sinc
decemb
cluster
patient
pneumonia
previous
unknown
caus
wuhan
china
research
chines
center
diseas
control
prevent
assess
lower
respiratori
tract
patient
discov
novel
coronaviru
sinc
name
novel
coronaviru
februari
world
health
organ
offici
name
novel
coronaviru
pneumonia
coronaviru
diseas
wherea
intern
committe
taxonomi
virus
name
sever
acut
respiratori
syndrom
coronaviru
huang
et
al
report
first
patient
exhibit
fever
cough
myalgia
andor
fatigu
common
symptom
ard
six
die
typic
find
chest
ct
scan
bilater
groundglass
opac
subsegment
area
consolid
earlier
time
outbreak
patient
like
report
exposur
food
huanan
seafood
wholesal
market
epidem
gradual
grow
clear
humantohuman
transmiss
preval
march
total
confirm
case
relat
death
among
case
occur
china
importantli
assess
noteworthi
influenza
virus
share
common
etiolog
occur
season
recent
global
influenza
associ
respiratori
mortal
occur
higher
frequenc
previous
report
septemb
presentday
patient
influenza
unit
state
onehalf
infect
influenza
viru
percentag
death
attribut
pneumonia
induc
influenza
global
epidem
jain
et
al
found
patient
influenza
admit
icu
die
anoth
studi
canada
show
overal
mortal
among
patient
critic
ill
day
common
symptom
infect
includ
fever
product
cough
wherea
gi
symptom
eg
nausea
vomit
diarrhea
less
common
furthermor
groundglass
opac
commonli
found
chest
ct
scan
patient
although
two
respirovirus
loom
epidem
differ
region
present
epidem
easili
propag
region
time
due
climat
chang
global
travel
individu
distinct
treatment
prognos
import
clinician
epidemiologist
accur
identifi
two
respirovir
infect
via
differenti
clinic
manifest
aim
current
studi
therefor
compar
differ
clinic
present
ard
patient
infect
vs
infect
provid
guidanc
differenti
diagnos
studi
question
aim
studi
explor
differ
clinic
present
pneumonia
patient
ard
mani
differ
ard
patient
ard
patient
clinic
present
outcom
compar
patient
ard
lower
sever
ill
score
present
lower
sofa
score
adjust
mortal
analysi
retrospect
casecontrol
studi
subject
confirm
use
result
laboratori
test
hospit
wuhan
pulmonari
hospit
hubei
provinc
china
decemb
februari
pneumonia
case
singlecent
prospect
cohort
studi
patient
ard
beij
chaoyang
hospit
china
case
confirm
use
laboratori
test
result
correspond
patient
hospit
march
decemb
patient
met
criteria
berlin
definit
diagnosi
ard
follow
fulfil
criteria
patient
ard
includ
studi
ethic
committe
beij
chaoyang
hospit
wuhan
pulmonari
hospit
approv
collect
clinic
data
includ
patient
infect
respect
cohort
written
inform
consent
obtain
patient
legal
guardian
cohort
inform
consent
patient
waiv
prospect
collect
analyz
data
patient
accord
polici
public
health
outbreak
investig
emerg
infecti
diseas
issu
nation
health
commiss
peopl
republ
china
demograph
clinic
data
patient
enter
electron
case
report
form
data
includ
follow
demograph
characterist
age
sex
underli
diseas
comorbid
clinic
symptom
fever
cough
sputum
dyspnea
chest
pain
rash
nausea
vomit
abdomin
pain
diarrhea
headach
sign
bodi
temperatur
heart
rate
respiratori
frequenc
bp
laboratori
test
blood
routin
test
arteri
blood
ga
analysi
blood
chemistri
microbiolog
findingsimag
lung
chest
ct
scan
antimicrobiolog
therapi
respiratori
support
complic
outcom
also
record
diagnos
patient
infect
base
clinic
present
imag
characterist
presenc
either
detect
sampl
either
respiratori
tract
blood
data
analysi
perform
use
spss
ibm
spss
statist
ibm
corpor
softwar
categor
variabl
summar
use
frequenc
percentag
continu
data
present
median
interquartil
rang
mannwhitney
u
test
use
continu
variabl
c
test
fisher
exact
test
use
categor
variabl
variabl
p
valu
univari
analysi
enter
multivari
logist
regress
analysi
identifi
independ
risk
factor
associ
p
valu
consid
statist
signific
median
age
patient
year
significantli
higher
patient
year
p
proport
male
subject
group
significantli
lower
group
p
term
underli
diseas
patient
histori
cardiovascular
diseas
wherea
patient
significantli
lower
p
signific
differ
histori
hypertens
diabet
chronic
airway
diseas
two
group
time
admiss
septic
shock
occur
patient
greater
report
patient
p
howev
median
sequenti
organ
failur
assess
sofa
score
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
patient
respect
lower
score
p
p
patient
signific
differ
durat
onset
ard
durat
onset
diagnosi
tabl
group
present
fever
cough
dyspnea
wherea
hemoptysi
less
common
furthermor
patient
product
cough
significantli
less
patient
p
proport
fatigu
myalgia
gi
symptom
patient
higher
patient
p
p
p
respect
tabl
median
pao
fio
patient
mm
hg
significantli
higher
mm
hg
patient
p
follow
biochem
test
aspart
transaminas
lactat
dehydrogenas
troponin
level
patient
significantli
lower
chestjournalorg
median
lymphocyt
concentr
patient
cellsml
median
lymphocyt
concentr
cell
ml
significantli
lower
patient
cellsml
p
cellsml
p
tabl
term
imag
characterist
groundglass
opac
chest
ct
scan
common
patient
patient
contrast
consolid
common
patient
p
fig
tabl
patient
receiv
antivir
therapi
oseltamivir
administ
patient
howev
patient
administ
varieti
antivir
treatment
includ
lopinavirritonavir
oseltamivir
ganciclovir
tradit
chines
medicin
addit
antivir
treatment
patient
receiv
glucocorticoid
significantli
higher
proport
patient
p
contrast
differ
dosag
cours
glucocorticoid
treatment
two
group
immunoglobulin
administ
patient
higher
administ
patient
p
tabl
term
respiratori
support
patient
receiv
convent
oxygen
therapi
initi
support
wherea
patient
receiv
mechan
ventil
p
howev
failur
rate
convent
oxygen
therapi
highflow
nasal
cannula
oxygen
therapi
noninvas
mechan
ventil
higher
patient
entir
process
treatment
proport
patient
receiv
highflow
nasal
cannula
oxygen
therapi
noninvas
mechan
ventil
invas
mechan
ventil
extracorpor
membran
oxygen
ecmo
significantli
higher
patient
p
tabl
term
prognos
patient
discharg
time
current
inhospit
mortal
patient
ard
wherea
patient
ard
p
sofa
score
use
adjust
mortal
patient
sofa
scoreadjust
mortal
patient
significantli
higher
patient
rate
ratio
ci
p
differ
durat
hospit
patient
day
patient
day
tabl
variabl
p
valu
univari
analysi
enter
multivari
logist
regress
analysi
compar
paramet
patient
patient
inclin
product
cough
ci
fig
tabl
outbreak
began
decemb
also
correspond
flu
season
current
studi
compar
clinic
cours
patient
ard
ard
found
compar
featur
patient
patient
like
exhibit
nonproduct
cough
obviou
constitut
symptom
fatigu
gi
symptom
preval
elderli
addit
imag
result
commonli
present
groundglass
opac
patient
howev
although
condit
patient
seem
critic
patient
differ
prognos
ard
patient
infect
vs
infect
fatigu
dri
cough
common
symptom
mean
incub
period
day
howev
addit
fever
product
cough
rhinorrhea
common
patient
median
incub
period
viru
day
therefor
specul
previou
research
current
find
infect
may
present
slow
onset
fewer
product
cough
obviou
system
symptom
compar
clinic
present
infect
current
studi
found
groundglass
opac
common
patient
patient
wherea
consolid
frequent
patient
consist
previou
studi
radiolog
find
patient
pneumonia
shi
et
al
show
diffus
bilater
groundglass
opac
predomin
pattern
abnorm
chest
ct
scan
within
week
follow
diseas
onset
addit
studi
pneumonia
shown
critic
case
present
area
consolid
ct
imag
without
groundglass
opac
addit
diffus
alveolar
damag
patholog
find
lung
indic
ard
accompani
cellular
fibromyxoid
exud
wherea
accompani
necrot
bronchiol
extens
hemorrhag
therefor
differenti
patholog
chang
may
present
distinguish
imag
characterist
clinic
assess
also
found
patient
receiv
wider
varieti
treatment
compar
patient
contrast
definit
treatment
measur
evid
approv
effect
therapi
one
hundr
clinic
studi
conduct
chines
research
interim
research
data
may
provid
help
current
urgent
demand
drug
treatment
applic
glucocorticoid
common
patient
current
studi
proport
patient
greater
patient
howev
differ
dosag
durat
glucocorticoid
two
group
observ
data
current
avail
suggest
glucocorticoid
treatment
respiratori
infect
increas
mortal
secondari
infect
rate
influenza
impair
clearanc
sarscov
middl
east
respiratori
syndrom
coronaviru
complic
corticosteroid
therapi
survivor
therefor
indic
glucocorticoid
care
evalu
patient
infect
may
accompani
ard
respiratori
support
case
accord
therapeut
strategi
ard
current
studi
found
sever
respiratori
failur
equal
patient
pao
fio
level
patient
higher
patient
respiratori
support
patient
initi
via
noninvas
method
ultim
yield
higher
failur
rate
ecmo
rescu
lung
injuri
sever
ard
eolia
trial
provid
inform
posterior
probabl
mortal
benefit
patient
acut
respiratori
failur
especi
term
report
success
applic
ecmo
ard
patient
influenza
specul
ecmo
may
also
potenti
treat
patient
howev
rapid
growth
case
lack
medic
resourc
medic
staff
limit
standard
respiratori
support
accord
relat
guidelin
current
studi
mortal
ard
patient
infect
accord
median
pao
fio
mm
hg
patient
current
studi
correspond
mortal
rate
consist
definit
ard
although
patient
studi
exhibit
significantli
lower
oxygen
patient
differ
mortal
rate
two
group
adjust
mortal
analysi
found
patient
significantli
wors
prognosi
patient
includ
case
current
studi
earli
stage
epidem
rapidli
grow
case
unknown
diseas
inadequ
respons
insuffici
medic
staff
lack
medic
suppli
advers
affect
treatment
prognos
case
therefor
novel
respiratori
infecti
diseas
rel
higher
mortal
rate
case
expect
experi
gain
treat
earli
patient
subsequ
case
may
benefit
better
standard
therapi
includ
specif
medic
treatment
respiratori
support
current
studi
limit
first
retrospect
studi
includ
data
two
independ
singlecent
cohort
may
result
unavoid
bia
second
condit
patient
sever
cohort
may
led
statist
disequilibrium
third
patient
still
hospit
time
manuscript
submiss
mean
mortal
rate
present
like
underestim
real
overal
hospit
mortal
rate
final
data
cohort
origin
span
wherea
data
cohort
origin
span
may
also
affect
studi
result
mani
differ
clinic
present
patient
ard
infect
either
compar
patient
ard
lower
sever
ill
score
present
lower
sofa
scoreadjust
mortal
futur
studi
investig
focu
welldesign
prospect
casecontrol
trial
larg
sampl
size
could
provid
experi
evid
regard
treatment
measur
author
contribut
b
take
respons
content
manuscript
includ
data
analysi
h
p
p
b
conceiv
idea
design
supervis
studi
draft
manuscript
full
access
data
take
respons
integr
data
x
r
r
w
c
l
g
q
q
z
x
l
l
collect
data
l
l
z
analyz
data
perform
statist
analysi
author
review
approv
final
version
manuscript
financialnonfinanci
disclosur
none
declar
role
sponsor
sponsor
role
design
studi
collect
analysi
data
prepar
manuscript
